Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial
Dona L Fleishaker, Juan A Garcia Meijide, Andriy Petrov…Volume:
14
Language:
english
DOI:
10.1186/ar3685
Date:
February, 2012
File:
PDF, 587 KB
english, 2012